Pharmaceutical packaging equipment refers to the equipment comprised of multiple equipment and its components, piping, instruments, electrical items and other related accessories which are all fabricated and assembled at the shop and usually mounted on the skid which are ready for connection and used for packaging of all pharmaceutical products, using flexible, and heat sealable material to form packages that are filled with a product and then sealed. The main types of products of pharmaceutical packaging equipment are primary packaging equipment, secondary packaging equipment, and labeling and sterilization equipment. Primary packaging equipment is in direct contact with the product itself and is referred to as a consumer unit. Primary packaging is what directly encases and contains the drug product. Secondary packaging equipment provides corrugated cardboard packaging print finished to a high standard. Secondary packaging is the exterior packaging of the primary packaging that groups packages and further protects or labels the drug product. Labeling and sterilization equipment is responsible for adding directions of use and sterilizing the packaging environment. The various types of pharmaceutical packaging equipment are blenders, granulators, tablet pressers, tablet coating machines, and allied machines. The pharmaceutical packaging equipment market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical packaging equipment market statistics, including pharmaceutical packaging equipment industry global market size, regional shares, competitors with a pharmaceutical packaging equipment market share, detailed pharmaceutical packaging equipment market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical packaging equipment industry. This pharmaceutical packaging equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pharmaceutical packaging equipment market size grew from $9.94 billion in 2022 to $11.06 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical packaging equipment market size is expected to grow to $16.34 billion in 2027 at a CAGR of 10.2%. An increase in ageing population is expected to increase the prevalence of age-related ailments, thus contributing to the growth of the pharmaceutical drugs and pharmaceutical packaging equipment market. The elderly population is increasing rapidly across the world, and it is expected to continue over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC) report, the population aged 65 years and above is expected to reach approximately 71 million by 2030 and 98 million by 2060 in the USA. It is estimated by 2030, China will have nearly half of the Parkinson’s disease population in the world, which can be attributed to the country’s aging population. This expected increase in the aging population suffering from age-related ailments is projected to drive the pharmaceutical packaging equipment market. The automatic packaging machine is increasingly utilized in the pharmaceutical packaging equipment market. The machine automatically supplies packing materials and contents, and other machines of the packaging process can be done automatically. For instance, in July 2020, OPTIMA Packaging Group, a Germany based company that designs and builds packaging equipment for pharmaceutical, consumer, nonwovens, and life science products, launched OPTIMA FPA. It is a unique platform that can assemble pen injectors both fully or semi-automatically. It is especially suitable as an entry-level system. Another new feature of the Optima FPA is the choice of adding a printer connected with 360-degree labeling. This product launch has increased the company’s automated packaging solutions portfolio. In February 2021, ProMach, a US-based packaging machinery company, acquired Serpa Packaging Solutions for an undisclosed amount. The addition of Serpa brings automated cartoning systems into ProMach’s portfolio and significantly expands ProMach’s specialized secondary packaging machinery and line integration capabilities for the rapidly growing pharmaceutical industry. Serpa Packaging Solutions is a US-based company that designs and manufactures pharmaceutical packaging equipment. Major players in the pharmaceutical packaging equipment market are Körber AG, Uhlmann Group, Marchesini Group S.p.A., Optima Packaging Group, Romaco Holding GmbH, MG2 s.r.l., Robert Bosch GmbH, Industria Macchine Automatiche S.p.A., Vanguard Pharmaceutical Machinery, Accutek Packaging Equipment Companies, MULTIVAC Group, Bausch + Ströbel Maschinenfabrik Ilshofen GmbH + Co. KG, ACG Group, Coesia S.P.A., Syntegon Technology, Trustar Pharma & Packing Equipment, Inline Filling Systems, Dara Pharmaceutical Packaging, ARPAC LLC, Romaco Group, N.K.P. Pharma, Ropack, and Trustar Pharma & Packing Equipment. North America was the largest region in the pharmaceutical packaging equipment market in 2022. Asia-Pacific was the second-largest market in the pharmaceutical packaging equipment market. The regions covered in the pharmaceutical packaging equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the pharmaceutical packaging equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The pharmaceuticals packaging equipment market consists of sales of accumulating and collating machines, blister packs, skin packs and vacuum packaging machines, bottle caps equipment, over-capping, lidding, closing, seaming and sealing machines, box, case, tray, and carrier forming, packing, unpacking, closing, and sealing machines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical packaging equipment market is segmented - 1) By Product: Primary Packaging Equipment, Secondary Packaging Equipment, Labelling And Sterialization Equipment 2) By Packaging Type: Liquids Packaging Equipment, Solid Packaging Equipment, Semi-Solid Packaging Equipment 3) By Equipment Type: Blenders, Granulators, Tablet Pressers, Tablet Coating Machine, Allied Machines 4) By Mode of Administration: Injectable Administration, Topical Administration, Oral Administration

Pharmaceutical processing seals refers to a seal that is used on process-connected equipment that is designed to be linked to an external system that contains process fluids in order to stop flammable or combustible process fluids from migrating into the wire system in non-hazardous zones or other classed locations. The main types of pharmaceutical processing seals are O-rings, gaskets, lip seals, D seals, and others. O-ring seals are used to prevent leaks from pumps, valves, cylinders, and connectors used in pharmaceutical processing. The different materials include metals, PTFE, silicone, nitrile rubber, EPDM, and others and are used in various applications such as manufacturing equipment, agitators, mixers, reactors, gearboxes, and others. The pharmaceutical processing seals market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical processing seals market statistics, including pharmaceutical processing seals industry global market size, regional shares, competitors with a pharmaceutical processing seals market share, detailed pharmaceutical processing seals market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical processing seals industry. This pharmaceutical processing seals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pharmaceutical processing seals market size grew from $2.04 billion in 2022 to $2.26 billion in 2023 at a compound annual growth rate (CAGR) of 10.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical processing seals market size is expected to grow to $3.12 billion in 2027 at a CAGR of 8.4%. The rise in chronic diseases is significantly contributing to the growth of the pharmaceutical processing seals market. Chronic diseases are defined as conditions that last more than a year and require ongoing medical care; they are global, national health issues that involve mortality and morbidity. These include heart disease, cancer, and diabetes. The rise in chronic diseases is driving up demand for pharmaceuticals, which in turn is driving up demand for pharmaceutical processing seals. For instance, according to the International Diabetes Federation, in 2021, 537 million adults are suffering from diabetes worldwide, which is a huge increase compared to the 463 million adults living with diabetes in 2019. Technological advancements are shaping the pharmaceutical processing seals market. Major companies operating in the pharmaceutical processing seals sector are focused on developing new technological solutions to meet consumer demand and strengthen their position. For instance, in November 2021, Crawford Packaging, a UK-based packaging machines company launched Evolution S, the top seal packaging technology machinery with an advanced tray sealing solution manufactured by Packaging Automation Ltd. Evolution S - Packing Automation has developed the world's most efficient tray sealing technology, raising the bar for precision and fast sealing rates while decreasing the packaging area's necessary footprint in a single lane configuration. In April 2021, DXP Cortech, a US-based distributor of pumps and process equipment has partnered with John Crane for an undisclosed amount. Through this partnership, DXP Cortech will act as a distributor for John Crane products in the California region and the extended west coast markets. It will also enable both businesses to better service their customers and expand their operations. John Crane is a US-based company that manufactures pharmaceutical processing seals, filtration systems, couplings, and packing systems. Major players in the pharmaceutical processing seals market are Trelleborg AB, Freudenberg Group, Flowserve Corporation, James Walker & Co., Parker-Hannifin Corporation, Saint-Gobain S.A, Garlock Sealing Technologies, John Crane, IDEX Corporation, Marco Rubber and Plastics, Technetics Group, Sealmatic, Maffs Seals Pvt Ltd., Quantech Sealing Systems, and EagleBurgmann India Pvt. Ltd. North America was the largest region in the pharmaceutical processing seals market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical processing seals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the pharmaceutical processing seals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmaceuticals processing seals market consists of sales of glass-to-metal seals, bodok seal, and a specialized gas sealing washer. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical processing seals market is segmented - 1) By Type: O-rings, Gaskets, Lip seals, D seals, Other types (Diaphragms and X-rings) 2) By Material: Metals, PTFE, Silicone, Nitrile Rubber, EPDM, Other materials 3) By Application: Manufacturing Equipment, Agitators, Mixers, Reactors, Gear Boxes, Other applications

Pharmaceutical glass packaging refers to a type of glass container which is prepared by a combination of different materials that are designed to ensure the safe transportation of various acidic and medical items. The use of glass in pharmaceutical packaging has many benefits, as glass is incredibly resistant to temperature changes. The main types of pharmaceutical glass packaging are ampoules, bottles, vials, syringes, cartridges, and other products. The ampoules refer to the sealed glass-containing solutions for hypodermic injections. Ampoules are used as packaging for many cosmetic and pharmaceutical products. The various drug types include generics, branded, and biologics that are made of different materials, such as type I, type II, and type III. The several applications include oral, injectable, nasal, and others. The pharmaceutical glass packaging market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical glass packaging market statistics, including pharmaceutical glass packaging industry global market size, regional shares, competitors with a pharmaceutical glass packaging market share, detailed pharmaceutical glass packaging market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical glass packaging industry. This pharmaceutical glass packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pharmaceutical glass packaging market size grew from $12.58 billion in 2022 to $13.7 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical glass packaging market size is expected to grow to $18.89 billion in 2027 at a CAGR of 8.4%. The growth of the pharmaceutical industry is expected to propel the growth of the pharmaceutical glass packaging market going forward. The pharmaceutical industry refers to the discovery, development, and manufacture of medications and drugs. Pharmaceutical glass packaging is used to pack and store medicines, strong alkalis, and acids. For instance, in 2021, according to the Indian Brand Equity Foundation, an India-based government agency, the Indian pharmaceutical market increased by 17.7% annually, up from 13.7% in July 2020, and the market revenue is expected to be over 12% in 2022. Therefore, the growth of the pharmaceutical industry is driving the growth of the pharmaceutical glass packaging market. Technological innovations are the key trend gaining popularity in the pharmaceutical glass packaging market. Major companies operating in pharmaceutical glass packaging are introducing new technologies to reinforce their position in the market. For instance, in January 2020, Gerresheimer, a Germany-based manufacturer of pharmaceutical glass packaging and glass injections for patients, launched Gx Elite vials, which are manufactured by using new technology, Gx RHOC systems. GX Elite vials: this is a new type I borosilicate glass packaging. These are high-end tubular glass vials. This is the safest product for customers and patients. In May 2021, Nipro, a Japan-based company operating in pharmaceutical glass packaging, acquired Piramida for an undisclosed amount. The acquisition is expected to increase the production capacity of Nipro. also helps in the strong development of Nipro’s ampoules and vials business. Piramida is a Latvia-based company that manufactures pharmaceutical glass containers, with premium quality glass vials and ampoules. Major players in the pharmaceutical glass packaging market are Gerresheimer, Corning Inc., Nipro, Stolzle-Oberglas GmBH, Bormioli Pharma S.r.l, West Pharmaceutical Services, West Pharmaceutical Services, Schott AG, Beatson Clark, Sisecam, O-I Glass, Arab Pharmaceutical Glass Co., Acme Vial & Glass Co., Hindusthan National Glass & Industries Limited, and United Glass Company. North America was the largest region in the pharmacuetical glass packaging market in 2022. The regions covered in the pharmaceutical glass packaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the pharmaceutical glass packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmaceutical glass packaging market consists of sales of borosilicate glass, treated soda-lime glass, regular soda-lime glass, and general purpose soda-lime. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical glass packaging market is segmented - 1) By Product: Ampoules, Bottles , Vials, Syringes, Cartridges, Other Product Types 2) By Drug Type: Generic, Branded, Biologic 3) By Material: Type I, Type II, Type III 4) By Application: Oral, Injectable, Nasal, Other Applications

Pharmaceutical drug delivery refers to the process or method of administering a drug to an animal or human to achieve a therapeutic effect. It is a formulation or apparatus that allows a medicinal material to target its site of action while avoiding nontarget cells, organs, or tissues. The main types of pharmaceutical drug delivery routes of administration are oral, ocular, pulmonary, nasal, injectable, topical, and other routes. The oral route refers to the administration of a drug through the mouth, which is the most common route for drug administration due to its sustained and controlled delivery, ease of administration, and feasibility for solid dosage forms. The different pharmaceutical drug delivery applications include infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications. The different end-users include hospitals, home care settings, ASC/Clinics, and other end users. The pharmaceutical drug delivery market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical drug delivery market statistics, including pharmaceutical drug delivery industry global market size, regional shares, competitors with a pharmaceutical drug delivery market share, detailed pharmaceutical drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug delivery industry. This pharmaceutical drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pharmaceutical drug delivery market size grew from $1597.53 billion in 2022 to $1752.39 billion in 2023 at a compound annual growth rate (CAGR) of 9.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical drug delivery market size is expected to grow to $2075.25 billion in 2027 at a CAGR of 4.3%. The growing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical drug delivery market going forward. Prevalence of chronic diseases refers to the total number of existing cases of chronic diseases in a population at a specific time. Pharmaceutical drug delivery helps the patients suffering from chronic diseases by delivering a pharmaceutical drug to a specific part of the body to treat different diseases. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, noncommunicable diseases kill 41 million people each year, equivalent to 71% of all deaths globally and cardiovascular diseases account for most of the deaths. Therefore, the growing prevalence of chronic diseases is driving the pharmaceutical drug delivery market. The adoption of nano-based drug delivery systems is a key trend gaining popularity in the pharmaceutical drug delivery market. The use of nanomaterials in pharmaceutical drug delivery can increase the cellular uptake of drugs because of the surface charge and time and they can increase the stability and water solubility of drugs. For instance, in March 2020, Bioavanta-Boston, a Switzerland-based chitosan nanoparticles research organization released Novochizol, unique polysaccharide nanotechnology that can be utilized to encapsulate any effective pharmaceutical additive such as a small molecule, or biologic for localized delivery and steady discharge in any organ or tissue, allowing for the treatment of severe COVID-19 infection in the lungs. In May 2022, Halozyme Therapeutics, a US-based biotechnology company acquired Antares Pharma for a deal amount of $960 million. With this acquisition, Halozyme targets to strengthen its position as a leading drug delivery company by including Antares specialty products. Antares Pharma is a US-based specialty pharmaceutical drug delivery company. Major players in the pharmaceutical drug delivery market are 3M Company, Bayer AG, Becton Dickinson And Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC., Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Sanofi S.A., AbbVie Inc., Amgen Inc., AstraZeneca plc., Boehringer Ingelheim, Boston Scientific Corporation, Bristol-Myers Squibb, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc., Kite Pharma, Nemera France SAS, Nimbus Therapeutics, SHL Medical AG., Teva Pharmaceuticals Industries Ltd., and West Pharmaceutical Services Inc., North America was the largest region in the pharmaceutical drug delivery market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this pharmaceutical drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the pharmaceutical drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The pharmaceutical drug delivery market includes revenues earned by entities by administering a pharmaceutical compound to achieve a therapeutic effect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced.It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical drug delivery market is segmented - 1) By Route of Administration: Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes 2) By Application: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications 3) By End-User: Hospitals, Home Care Settings, ASC/Clinics, Other End Users

Pharmaceutical logistics refers to the integration of information flow, material handling, production, packaging, inventory, and chain management of prescription medicines. The main types of pharmaceutical logistics are cold chain logistics and non-cold chain logistics. Cold chain logistics refers to the technology and process that is used for the safe transport of goods that are temperature-sensitive along the supply chain. The different components in pharmaceutical logistics include storage, transportation, and monitoring components. The procedures include picking, storage, retrieval systems, and handling systems. Transporation includes sea freight, air freight, and overland. These are used in applications such as biopharma, chemical pharma, and specialty pharma. The pharmaceutical logistics market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical logistics market statistics, including pharmaceutical logistics industry global market size, regional shares, competitors with a pharmaceutical logistics market share, detailed pharmaceutical logistics market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical logistics industry. This pharmaceutical logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global pharmaceutical logistics market size grew from $98.94 billion in 2022 to $109.34 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical logistics market size is expected to grow to $161.98 billion in 2027 at a CAGR of 10.3%. The rise in demand for pharmaceutical products is expected to propel the growth of the pharmaceutical logistics market going forward. Pharmaceutical products refer to any medicine that is for human use that is available in finished dosage form and is controlled by pharmaceutical legislation. Logistics help pharmaceutical products handle the procurement, storage, and transportation of resources. For instance, according to an article by India Brand Equity Foundation, an Indian government export promotion agency, in 2021 the Indian pharmaceutical market increased annually to 17.7% from 13.7% in July 2020. Therefore, a rise in demand for pharmaceutical products is driving the growth of the pharmaceutical logistics market. Technological advancements are a key trend gaining popularity in the pharmaceutical Logistics market. Major companies operating in the pharmaceutical logistics market are coming up with new technologies such as cloud-based supply chain functions, IoT technology, and others to sustain their position in the market. For instance, in May 2020, United Parcel Service, a US-based shipping, receiving, and supply chain management company, expanded its healthcare logistics with the launch of UPS Premier. UPS Premier is part of the company’s ongoing service and technology upgrades. It uses next-generation sensor technology and monitoring to improve service reliability with priority handling and improved visibility for critical healthcare packages. This technology is a major breakthrough for managing time-sensitive, temperature-sensitive, and patient-sensitive healthcare shipments. In March 2022, Lineage Logistics LLC, a US-based warehousing and logistics management company, acquired MTC Logistics for an undisclosed amount. This acquisition adds Lineage Logistics, four cold storage facilities along the U.S. East and Gulf Coasts, including 38M cubic feet and over 1.13lakh pallet positions. MTC Logistics is a US-based cold storage facility operating in the pharmaceutical logistics market. Major players in the pharmaceutical logistics market are Agility Public Warehousing Company K.S.C.P., Air Canada, CEVA Logistics, DB Schenker, Deutsche Post AG, FedEx Corporation, LifeConEx LLC, Marken, United Parcel Service , Kerry Logistics Network Limited, Panalpina, Kuehne + Nagel International AG, Sofrigam SA, CONTINENTAL Carriers Pvt Ltd and DSV A/S. North America was the largest region in the pharmaceutical logistics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pharmaceutical logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The pharmaceutical logistics market includes revenues earned by entities by providing cold chain storage, asset ownership services, and quality management systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced.It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical logistics market is segmented - 1) By Type: Cold Chain Logistics, Non-Cold Chain Logistics 2) By Component: Storage, Transportation, Monitoring Components 3) By Procedure: Picking, Storage, Retrieval Systems, Handling Systems 4) By Transportation: Sea Freight, Air Freight, Overland 5) By Application: Bio Pharma, Chemical Pharma, Speciality Pharma

Generic pharmaceuticals refer to a drug that was developed to have the same dosage form, safety, strength, mode of administration, quality, performance attributes, and intended use as an already marketed brand-name drug. The action and clinical benefits of a generic drug are identical to those of a brand-name drug. The three main types of generic pharmaceuticals are biosimilar; simple generic, and super generic. A biosimilar is a biological product that is very similar to a reference biologic and has no clinically significant differences in terms of safety, purity, or potency. The drugs are delivered through oral, injectable, dermal/topical, and inhalers that are used for various therapies such as CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, and oncology. The various distribution channels involved is hospital pharmacies, retail pharmacies, and online pharmacies. The generic pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides generic pharmaceuticals market statistics, including generic pharmaceuticals industry global market size, regional shares, competitors with a generic pharmaceuticals market share, detailed generic pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the generic pharmaceuticals industry. This generic pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global generic pharmaceuticals market grew from $332.43 billion in 2022 to $358.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The generic pharmaceuticals market is expected to grow from $453.19 billion in 2027 at a CAGR of 6.0%. The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceutical market. As more individuals are diagnosed with chronic diseases, they look for more medicines for treatment. Branded drugs come at a premium price, while generic drugs are available at a lower cost and have the same chemical composition as branded drugs. The low cost and same chemical composition and strength of generic drugs make a patient buy generic drugs instead of branded drugs. If it is a chronic disease, the treatment goes on for a longer period, and hence, the sales of generic drugs also increase. For instance, according to the WHO (World Health Organization), over the next 10 years, the number of deaths due to chronic disease is projected to increase by 17%. Also, in 2020, almost 3-quarters of all deaths in the world are due to chronic diseases. The lack of awareness about generic drugs is one of the restraints on the generic pharmaceutical market. The high marketing and advertisement of branded drugs overshadow the availability of generic drugs, which are a substitute for expensive branded drugs. Thus, consumers opt for branded drugs even though the generic drugs carry the same chemical formulation as their counter-branded drugs. According to an article published on CVS HEALTH, many doctors and pharmacists preferred to offer branded drugs to their patients over generic drugs. This prevents the patients to go for generic drugs as they develop a preconceived notion of generic drugs not being at par with branded drugs. For example, according to research conducted by Sahana K Hebbar, in the International Journal of Basic & Clinical Pharmacology, out of 100 patients and 50 non-medical staff, 95% of the patients and 60% of the non-medical staff didn't know about generic drugs. Thus, a lack of awareness about the availability of generic drugs hampers the generic pharmaceutical market. 3D printing technology can transform the manufacturing of drugs in the generic pharmaceutical market. 3D printed pharmaceuticals help improve R&D productivity and deliver new benefits to patients. 3D printing allows the manufacturer to produce drugs with customised size, shape, and texture, which is not possible in traditional manufacturing of generic drugs. 3D printing can help the manufacturer to make generic drugs that have different release dates, appearances, and tastes. For example, GlaxoSmithKline (GSK) completed a study where ultraviolet (UV) and 3D printing were used to manufacture tablets to treat Parkinson's disease. Martin Wallace, director of GSK Technology, said that GSK is investing in 3D printing to manufacture pills and tablets. Also, Aprecia pharmaceutical company launched 'ZipDose' technology, which manufactures 3D printed drugs. The drug manufacturers must comply with the CGMP (Current Good Manufacturing Practice) regulations that come under the US Food and Drug Administration (FDA) which includes generic pharmaceuticals. The CGMP regulations require manufacturers to maintain a minimum quality standard for the methods, controls, and facilities used in the manufacturing, packaging, and processing of drug products. Part- 99 of chapter 1 under title 21-Food And Drugs of CFR (Code of Federal Regulations) contains subparts from A to H. The whole part-99 describes the guidelines that need to be followed by drug manufacturers regarding the dissemination of information on human drugs, including biologics, and devices. The guidelines concern the safety, effectiveness, or benefit of use that is not included in the approved labelling for a drug or device approved by the Food and Drug Administration for marketing. The guidelines regulate the information regarding the drugs that should be delivered to the health care practitioner, pharmacy benefit manager, health insurance issuer, group health plan, or federal or state government agency. In January 2020, ANI Pharmaceuticals, Inc., a USA-based integrated specialty pharmaceutical company focused on developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceuticals, acquired Commercial and Pipeline Generic Products from American Pharmaceuticals, Ltd. for $52.5M in cash. This acquisition substantially increases ANI Pharmaceuticals, Inc.’s commercial portfolio and late-stage generic pipeline. Amerigen Pharmaceuticals is a USA-based company focused on the development, manufacture, and sale of high-quality generic pharmaceutical products. Major players in the generic pharmaceuticals market are Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.), Sun Pharmaceutical, Lupin Limited, Endo International PLC., Dr Reddy's Laboratories, Apotex Holdings, Fresenius Kabi Ag, Aurbindo Pharma, Aspen Pharmacare, Sanofi, Cipla, Hikma Pharmaceuticals, Stada Arzneimittel, Krka Group, Nichi-Iko Pharmaceutical, Valeant, Zydus Cadila, Merck & Co., Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Nexus Pharmaceuticals, Novo Nordisk, Ranbaxy Laboratories Ltd., Sawai Pharmaceuticals, Novartis AG, Pfizer and Johnson & Johnson Services. North America was the largest region in the generic pharmaceuticals market in 2022. The Middle East is expected to be the fastest-growing region in the global generic pharmaceuticals market during the forecast period. The regions covered in the global generic pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the generic pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The generic pharmaceuticals market consists of sales of paracetamol, cefixime, amoxicillin, and ofloxacin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global generic pharmaceuticals market is segmented - 1) By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By Type: Biosimilar, Simple Generic, Super Generic 4) By Drug Delivery: Oral, Inectables, Dermal/Topical, Inhaler

Veterinary pharmaceuticals are a class of drugs that are pharmacologically active and used to control, prevent, and treat diseases in animals. They have an effect when administered to animals and are rapidly broken down into active ingredients due to small intestine metabolism. The main types of veterinary pharmaceuticals include veterinary vaccines, veterinary antibiotics, veterinary parasiticides, and other types. Veterinary vaccines provide protection against one or more diseases, which can lower the severity or prevent certain diseases entirely. The routes of administration include oral and other routes of administration for animal types, including companion animals and livestock animals. The vaccines include inactivated vaccines, attenuated vaccines, and recombinant vaccines. The veterinary pharmaceuticals research report is one of a series of new reports from The Business Research Company that provides veterinary pharmaceuticals statistics, including veterinary pharmaceuticals industry global market size, regional shares, competitors with veterinary pharmaceuticals share, detailed veterinary pharmaceuticals segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmaceuticals industry. This veterinary pharmaceuticals research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global veterinary pharmaceuticals market size will grow from $28.43 billion in 2022 to $30.2 billion in 2023 at a compound annual growth rate (CAGR) of 6.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global veterinary pharmaceuticals market size is expected to grow from $37.12 billion in 2027 at a CAGR of 5.3%. The increase in the prevalence rate of diseases among animals serves as one of the major drivers for the veterinary pharmaceuticals market. The increase in the incidence of diseases in livestock and companion animals will require medicines to treat the animals for the diseases. For instance, according to the Banfield State of Pet Health Report, the prevalence of diabetes in dogs has increased by 79.7% from 13.1 cases per 10,000 to 23.6 cases whereas the prevalence rate increased by 18% in cats. The increase in the prevalence rate of diseases among animals results in an increased demand for veterinary pharmaceuticals. The veterinary pharmaceuticals market is being restrained by a lack of awareness about animal healthcare. According to the Animal Welfare Act 2006, proper healthcare means the pet should have regular vaccinations, a suitable diet, protection from pain and suffering, suffering and should be free from any kind of disease. According to the PDSA Animal Wellbeing (PAW) UK report, only 38% of people in the UK are aware of this legislation which shows a very less proportion of the population is aware of animal healthcare and acts as a major restraint for the market. The rise of generic drugs for animal care is being seen as the latest trend in the veterinary pharmaceuticals market. The economical nature of generic drugs enables pet lovers to take care of their pets efficiently. The FDA has approved 22 generic animal drugs for cats and dogs, which has increased the adoption of generic drugs by veterinarians. According to a survey conducted on 520 veterinarians by Brakke and Trone Brand Energy Inc., around 80% of the veterinarians confirmed that they are using generic drugs to save the pet owners’ money. However, the lower margin of profit given by generic drug manufacturers compared with the heavy margins of branded drugs needs to be looked into by veterinarians. The veterinary pharmaceuticals market is regulated by government agencies such as European Medicines Agency (EMA), USFDA (the US Food and Drug Administration), and others. For instance, the EU agencies require 6 to 12 months to approve veterinary medicinal products. Moreover, it requires all parts of the registration dossier to be submitted together, unlike the US-FDA, which accepts phased submissions. The US-FDA assesses each technical section for 6 months which may be extended to another 6 month cycle if questions or concerns are raised. However, the technical sections’ assessment is done simultaneously, and therefore, the manufacturers should identify the time-consuming steps and plan the work accordingly and estimate the date of approval. Also, the license validity and renewal of the application in the EU region is very difficult upon the existing regulatory policies. Therefore, the manufacturers of veterinary pharmaceuticals should plan well, communicate effectively to minimize the costs and reduce timelines. Major players in the veterinary pharmaceuticals market are Merck & Co. Inc., Zoetis Inc., Eli Lilly and Company, Bayer AG, Boehringer Ingelheim GmbH, Perrigo Company PLC., Virbac SA, Dechra Pharmaceuticals PLC., CevaSanteAnimale, and Aratana Therapeutics. North America was the largest region in the veterinary pharmaceuticals market in 2022. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market. The regions covered in the global veterinary pharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the veterinary pharmaceuticals market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The veterinary pharmaceuticals market consists of sales of biological drugs, biosimilars, monoclonal antibodies, sedatives, and antihistaminic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global veterinary pharmaceuticals market is segmented - 1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Types 2) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores 3) By Route of Administration: Oral, Other Routes Of Administration 4) By Animal Type: Companion Animals, Livestock Animals 5) By Vaccines: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines

Radiopharmaceuticals Market Definition

The radiopharmaceuticals market consists of sales of radiopharmaceuticals and related services by entities (organizations, sole traders, and partnerships) that produce radiopharmaceuticals used in diagnosing and/or treating cancer, cardiovascular diseases, and other diseases. Radiopharmaceuticals are radioactive compounds administered to the patients, monitored via specific imaging devices, and used for diagnostic and therapeutic purposes. Radiopharmaceuticals, also known as nuclear medicine, are radioactive substances that are used in the scintigraphy technique, also known as a gamma scan, this is a diagnostic test in nuclear medicine, where radioisotopes attached to drugs that travel to intended organ or tissue are taken internally to create images of organs or tissues. A radiopharmaceutical is a molecule that consists of a radioisotope tracer attached to a pharmaceutical. After entering the body, the radio-labelled pharmaceutical will accumulate in a specific organ or tumor tissue. For delivering radioactivity directly to bones, bone scan imaging is used. The gamma rays released by the radioisotope can be detected by a medical instrument known as a gamma camera. Radiopharmaceuticals are agents that are used to diagnose and treat medical conditions. They can be administered to the patient through different routes of administration. They can be given orally, by injection, or by placing them in the eye or the bladder.